These inconsistent findings underscore that current evidence is largely bioinformatics-based and lacks mechanistic validation, indicating that the proposed oncogenic role of SRSF11 in ovarian cancer remains preliminary. The gene discussed is SRSF11; the disease is ovarian cancer.